Molecular characteristics of screen-detected vs symptomatic breast cancers and their impact on survival
Top Cited Papers
Open Access
- 22 September 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 101 (8), 1338-1344
- https://doi.org/10.1038/sj.bjc.6605317
Abstract
Background: Methods: Results: Conclusion:Keywords
This publication has 30 references indexed in Scilit:
- Prevalent cases in observational studies of cancer survival: do they bias hazard ratio estimates?British Journal of Cancer, 2009
- Molecular Subtypes of Breast Cancers Detected in Mammography Screening and Outside of ScreeningClinical Cancer Research, 2008
- Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancerBMC Cancer, 2008
- Screen-detected vs symptomatic breast cancer: is improved survival due to stage migration alone?British Journal of Cancer, 2008
- Prognostic markers in triple‐negative breast cancerCancer, 2006
- Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiationThe Journal of Pathology, 2006
- High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analysesInternational Journal of Cancer, 2005
- Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast CarcinomaClinical Cancer Research, 2004
- Repeated observation of breast tumor subtypes in independent gene expression data setsProceedings of the National Academy of Sciences of the United States of America, 2003
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998